AS
Aditya Sharma
Birla Institute of Technology and Science, Pilani - Dubai Campus, Regional Centre for Biotechnology, University of Delhi - South Campus, Pondicherry University, All India Institute of Medical Sciences
Employment
-
Birla Institute of Technology and Science, Pilani - Dubai Campus Assistant Professor2023 - Present
-
Regional Centre for Biotechnology Project Scientist I2022 - 2023
-
All India Institute of Medical Sciences Senior Project Associate2021 - 2022
-
Delhi Technological University Research Fellow and Teaching Assistant2011 - 2013
-
National Institute of Immunology Junior Research Fellow2011 - 2011
-
Sri Venkateswara College Research Trainee2010 - 2011
Education
-
University of Delhi - South Campus Ph.D2013 - 2020
-
Pondicherry University M.Sc.2008 - 2010
-
Sri Venkateswara College B.Sc. (Hons)2005 - 2008
Projects & Funding
Projects & funding information is unavailable.
Publications (11)
- ARL15 and its Multiple Disease Association: Emerging Functions and Potential Therapeutic Application Save
- ARL15, a GTPase implicated in rheumatoid arthritis, potentially repositions its truncated N-terminus as a function of guanine nucleotide binding. Save
- Computational insight into the three-dimensional structure of ADP ribosylation factor like protein 15, a novel susceptibility gene for rheumatoid arthritis Save
- Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors. Save
- Rare variants in Protein tyrosine phosphatase, receptor type A (PTPRA) in schizophrenia: Evidence from a family based study. Save
- Rare Variants in Tissue Inhibitor of Metalloproteinase 2 as a Risk Factor for Schizophrenia: Evidence From Familial and Cohort Analysis Save
- Development of Lead Molecules for Complex Genetic Disorders: Rheumatoid Arthritis – A Case Study Save
- Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders Save
- Pharmacophore modeling and virtual screening studies to design potential COMT inhibitors as new leads. Save
- Identification of potential drug targets in Yersinia pestis using metabolic pathway analysis: MurE ligase as a case study Save